JP3406437B2 - Water-in-oil emulsion cosmetics - Google Patents
Water-in-oil emulsion cosmeticsInfo
- Publication number
- JP3406437B2 JP3406437B2 JP27712295A JP27712295A JP3406437B2 JP 3406437 B2 JP3406437 B2 JP 3406437B2 JP 27712295 A JP27712295 A JP 27712295A JP 27712295 A JP27712295 A JP 27712295A JP 3406437 B2 JP3406437 B2 JP 3406437B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- water
- weight
- particle size
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 15
- 239000007762 w/o emulsion Substances 0.000 title claims 2
- 239000003921 oil Substances 0.000 claims description 40
- 239000000839 emulsion Substances 0.000 claims description 21
- 229920001296 polysiloxane Polymers 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 16
- -1 Sorbitan fatty acid esters Chemical class 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 229920002545 silicone oil Polymers 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 229920001971 elastomer Polymers 0.000 claims description 6
- 239000000806 elastomer Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- 239000012190 activator Substances 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 238000013329 compounding Methods 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 235000019198 oils Nutrition 0.000 description 25
- 239000012071 phase Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 229910002012 Aerosil® Inorganic materials 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000008385 outer phase Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ASKIVFGGGGIGKH-UHFFFAOYSA-N isostearic acid monoglyceride Natural products CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- AZNRMKYTAHHKAC-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OC(CO)CO AZNRMKYTAHHKAC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- PHDVPEOLXYBNJY-KTKRTIGZSA-N 2-(2-hydroxyethoxy)ethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCO PHDVPEOLXYBNJY-KTKRTIGZSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000219053 Rumex Species 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229910052799 carbon Chemical group 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940092288 polyethylene glycol 11000 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 238000006227 trimethylsilylation reaction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は油中水型乳化化粧料に関
し、さらに詳細には、外相の粘度を高めることなく、良
好な乳化状態を呈し、温度や経時による変化がなく、の
びのよく、さっぱりとした良好な使用感を有する油中水
型乳化化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a water-in-oil type emulsion cosmetic, and more specifically, it exhibits a good emulsified state without increasing the viscosity of the outer phase, has no change with temperature or aging, and spreads well. The present invention relates to a water-in-oil type emulsion cosmetic having a refreshing and good feeling.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】従
来、油中水型乳化化粧料は、外相(油相)の粘度を高く
し、固形・半固形型油分を配合することで安定性の高い
ものを得ていたため、油っぽく・べたつく使用感とな
り、化粧料としての評価は低かった。しかしその後、比
較的多くの水相を含有し、かつ油相中の固形・半固形油
分を大幅に少なくすることの可能な乳化法として、特開
昭53−21393号「油中水型乳化剤組成物」、特開
昭61−129033号「油中水型乳化組成物」などが
開発された。しかしながら、これらの乳化組成物を含有
する乳化化粧料も同様に外相の粘度を高くして安定性の
高いものを得ていたため、肌への塗布時に伸びが悪く、
さっぱり感が足りないという欠点があった。このため、
外相の粘度を低くしても安定性が良好であり、伸びがよ
く、さっぱりとした使用感の良好な油中水型乳化化粧料
の開発が望まれていた。2. Description of the Related Art Conventionally, water-in-oil type emulsion cosmetics have high stability by increasing the viscosity of the outer phase (oil phase) and blending solid / semi-solid type oil components. Since the product was obtained, it had a greasy and sticky feel, and was not highly evaluated as a cosmetic. However, thereafter, as an emulsification method containing a relatively large amount of water phase and capable of significantly reducing the solid / semisolid oil content in the oil phase, JP-A-53-21393 “water-in-oil type emulsifier composition” is used. , "JP-A-61-29033," water-in-oil type emulsion composition "and the like. However, the emulsified cosmetics containing these emulsified compositions also have a high stability by increasing the viscosity of the outer phase in the same manner, and thus have poor elongation when applied to the skin,
There was a drawback that the feeling was not sufficient. For this reason,
It has been desired to develop a water-in-oil type emulsion cosmetic which has good stability even when the viscosity of the outer phase is lowered, has good elongation, and has a refreshing feeling of use.
【0003】[0003]
【課題を解決するための手段】本発明は前記従来の技術
の課題に鑑みなされたものであり、本発明者らは鋭意研
究を重ねた結果、吸油性が高い粉体でありかつ粒径の異
なる粉体を特定の重量比で組み合わせた混合粉体と特定
の油分とを用いることで、外相の粘度を高めることな
く、伸びがよく、さっぱりとした使用感で、かつ安定性
が良好な油中水型乳化化粧料が得られることを見い出
し、本発明を完成した。The present invention has been made in view of the above-mentioned problems of the prior art, and as a result of intensive studies by the present inventors, the present invention has revealed that it is a powder having a high oil absorption and a particle size of By using a mixed powder in which different powders are combined at a specific weight ratio and a specific oil content, an oil that has good elongation, a refreshing feeling of use, and good stability without increasing the viscosity of the outer phase The inventors have found that a water-in-water emulsion cosmetic can be obtained and completed the present invention.
【0004】すなわち本発明は、(A)平均粒径2.0
〜5.0μmで粒径分布1〜15μmのオルガノポリシ
ロキサンエラストマー球状粉体と(B)平均粒径0.2
μm以下の疎水化シリカ粉体とからなり、(A)対
(B)の割合が重量比で1:0.1〜1:5である混合
粉体と、(C)総油相成分の30重量%以上がシリコー
ン油である油相と、(D)HLBが7以下の乳化剤と、
(E)水とからなることを特徴とする油中水型乳化化粧
料である。That is, according to the present invention, (A) an average particle size of 2.0
˜5.0 μm particle size distribution of 1 to 15 μm organopolysiloxane elastomer spherical powder and (B) average particle size 0.2
a mixed powder consisting of hydrophobized silica powder having a particle size of less than or equal to μm and having a weight ratio of (A) to (B) of 1: 0.1 to 1: 5; An oil phase having a weight percentage of silicone oil of not less than (D) an HLB of 7 or less;
(E) A water-in-oil type emulsion cosmetic comprising water.
【0005】以下本発明の構成について詳述する。本発
明の(A)成分である平均粒径2.0〜5.0μmで粒
径分布1〜15μmのオルガノポリシロキサンエラスト
マー球状粉体の詳細は特公平4−66446号公報、特
開平2−243612号公報および特公平4−1716
2号公報に記載されており、市販品としては、例えば、
トレフィルE−505C、トレフィルE−506C(東
レ・ダウコーニング・シリコーン株式会社製商品名)が
挙げられる。The structure of the present invention will be described in detail below. The details of the organopolysiloxane elastomer spherical powder having an average particle size of 2.0 to 5.0 μm and a particle size distribution of 1 to 15 μm, which is the component (A) of the present invention, are described in JP-B-4-66446 and JP-A-2-243612. Publication and Japanese Patent Publication No. 4-1716
No. 2 publication, examples of commercially available products include, for example,
Examples include Trefil E-505C and Trefil E-506C (trade name, manufactured by Toray Dow Corning Silicone Co., Ltd.).
【0006】また、(B)成分である平均粒径0.2μ
m以下の疎水化シリカ粉体は、表面の親水性水酸基をト
リメチルシリル化あるいはジメチルシリル化されたもの
で、具体的には、トリメチルシリル化されたものでは、
AEROSIL R813(日本アエロジル株式会社製
商品名)、ジメチルシリル化されたものではAEROS
IL R972、R974(日本アエロジル株式会社製
商品名)などが挙げられる。The average particle size of the component (B) is 0.2 μm.
The hydrophobized silica powder of m or less is obtained by subjecting the hydrophilic hydroxyl groups on the surface to trimethylsilylation or dimethylsilylation. Specifically, in the case of trimethylsilylated,
AEROSIL R813 (trade name of Nippon Aerosil Co., Ltd.), which is dimethylsilylated AEROS
IL R972, R974 (trade name of Nippon Aerosil Co., Ltd.) and the like can be mentioned.
【0007】(A)成分および(B)成分は、混合して
用いられ、その範囲は、(A)対(B)の割合が重量比
で1:0.1〜1:5、更に好ましくは1:0.1〜
1:3である。(A)と(B)の混合比が(A)1に対
し(B)0.1未満であれば安定性的に悪い傾向とな
り、5以上であれば、使用感触的にべたつきを生じる。The components (A) and (B) are used as a mixture, and the range thereof is such that the weight ratio of (A) to (B) is 1: 0.1 to 1: 5, and more preferably. 1: 0.1
It is 1: 3. If the mixing ratio of (A) and (B) is less than (B) 0.1 with respect to (A) 1, stability tends to be poor, and if it is 5 or more, stickiness is produced when used.
【0008】本発明においては、(C)総油相成分の3
0重量%以上がシリコーン油である油相が用いられる
が、このシリコーン油は、使用感を向上させるために必
要な成分である。配合されるシリコーン油としては、メ
チルポリシロキサン、メチルフェニルポリシロキサン、
メチルハイドロジェンポリシロキサン、デカメチルポリ
シロキサン、メチルポリシロキサン、オクタメチルシク
ロテトラシロキサン、ドデカメチルシクロヘキサシロキ
サン、高重合メチルポリシロキサンなどを挙げることが
できる。これらのシリコーン油は、総油分中に30重量
%以上配合される。30重量%未満の配合量では使用性
的にさっぱりとした使用感は得られない。In the present invention, (C) the total oil phase component of 3
An oil phase containing 0% by weight or more of silicone oil is used, and this silicone oil is a component necessary for improving the feeling of use. Silicone oils to be blended include methylpolysiloxane, methylphenylpolysiloxane,
Examples thereof include methyl hydrogen polysiloxane, decamethyl polysiloxane, methyl polysiloxane, octamethyl cyclotetrasiloxane, dodecamethyl cyclohexasiloxane, and highly polymerized methyl polysiloxane. These silicone oils are blended in an amount of 30% by weight or more in the total oil content. If the blending amount is less than 30% by weight, a refreshing feeling in terms of usability cannot be obtained.
【0009】本発明に配合される(C)成分のうち、シ
リコーン油以外の油分としては、動植物油としてアボガ
ド油、ツバキ油、マカデミアナッツ油、トウモロコシ
油、月見草油、ミンク油、ホホバ油、ナタネ油、ヒマシ
油、ヒマワリ油、カカオ油、ヤシ油、コメヌカ油、オリ
ーブ油、ラノリン、スクワレン等の天然動植物油脂類、
流動パラフィン、スクワラン、ミリスチン酸イソプロピ
ル、パルミチン酸イソプロピル、ステアリン酸イソプロ
ピル、2エチルヘキサン酸グリセロール、トリ2−エチ
ルヘキサン酸グリセリル、テトラ2−エチルへキサン酸
ペンタエリスリット等の脂肪酸エステル類、ジエチレン
グリコールモノプロピルエーテル、ポリオキシエチレン
ポリオキシプロピレンペンタエリスリトールエーテル、
ポリオキシプロピレンブチルエーテル、リノール酸エチ
ル等の極性オイルなどを挙げることができる。Among the components (C) to be blended in the present invention, oils other than silicone oil include avocado oil, camellia oil, macadamia nut oil, corn oil, evening primrose oil, mink oil, jojoba oil and rapeseed oil as animal and vegetable oils. , Natural oils and plants such as castor oil, sunflower oil, cocoa oil, coconut oil, rice bran oil, olive oil, lanolin, and squalene.
Liquid paraffin, squalane, isopropyl myristate, isopropyl palmitate, isopropyl stearate, glycerol 2-ethylhexanoate, glyceryl tri-2-ethylhexanoate, fatty acid esters such as pentaerythritol tetra-2-ethylhexanoate, diethylene glycol monopropyl Ether, polyoxyethylene polyoxypropylene pentaerythritol ether,
Examples thereof include polar oils such as polyoxypropylene butyl ether and ethyl linoleate.
【0010】これらの油分は、上記混合粉末(A)+
(B)と(C)の割合が1:5〜1:30(重量比)、
さらに好ましくは1:6〜1:20(重量比)で配合す
ることが望ましい。(A)+(B)1に対し(C)5未
満の場合、および30を超えた場合はいずれも乳化安定
性が悪くなる傾向がある。本発明において、(A)+
(B)+(C)の配合量は、9.0〜90.0重量%が
望ましい。These oils are the above-mentioned mixed powder (A) +
The ratio of (B) and (C) is 1: 5 to 1:30 (weight ratio),
More preferably, it is desirable to mix in a ratio of 1: 6 to 1:20 (weight ratio). When (C) is less than 5 and more than 30 with respect to (A) + (B) 1, the emulsion stability tends to deteriorate. In the present invention, (A) +
The blending amount of (B) + (C) is preferably 9.0 to 90.0% by weight.
【0011】本発明の油中水型乳化化粧料中に配合され
る(D)成分のHLBが7以下の乳化剤としては、ソル
ビタンモノラウレート、ソルビタンモノオレート、ソル
ビタンモノイソステアレート、ソルビタントリステアレ
ートなどのソルビタン脂肪酸エステル類、グリセロール
モノステアレート、グリセロールモノオレート、グリセ
ロールイソステアレートなどのグリセロール脂肪酸エス
テル類、POE(5)、POE(7.5)、POE(1
0)硬化ヒマシ油などのポリオキシエチレン硬化ヒマシ
油、ポリエーテル系のシリコーン活性剤などが挙げられ
る。そのうち、特にポリエーテル系のシリコーン活性剤
が好ましく、具体的には、下記化学式(1)の構造のも
のが挙げられる。Examples of the emulsifier having a HLB of 7 or less as the component (D) to be incorporated in the water-in-oil type emulsion cosmetic of the present invention include sorbitan monolaurate, sorbitan monooleate, sorbitan monoisostearate and sorbitan tristea. Sorbitan fatty acid esters such as glycerol, glycerol monostearate, glycerol monooleate, glycerol fatty acid esters such as glycerol isostearate, POE (5), POE (7.5), POE (1
0) Polyoxyethylene hydrogenated castor oil such as hydrogenated castor oil and polyether-based silicone activator. Among them, a polyether type silicone activator is particularly preferable, and specific examples thereof include those having the structure of the following chemical formula (1).
【0012】[0012]
【化1】 [Chemical 1]
【0013】(式中、Rは水素原子または炭素数1〜5
のアルキル基を示し、mは平均で1〜150、nは平均
で1〜50、aおよびbは平均で0〜35の数を示
す。)
(D)成分の配合量は、系全体の0.1〜5.0重量%
が好ましい。(In the formula, R represents a hydrogen atom or a carbon number of 1 to 5)
In the formula, m is 1 to 150 on average, n is 1 to 50 on average, and a and b are 0 to 35 on average. ) The content of the component (D) is 0.1 to 5.0% by weight of the whole system.
Is preferred.
【0014】本発明の(E)成分である水は、系中に
9.0〜90.0重量%配合される。The component (E) of the present invention, water, is mixed in the system in an amount of 9.0 to 90.0% by weight.
【0015】本発明の油中水型乳化化粧料には、前記必
須成分の他に、パラアミノ安息香酸、ホモメチル−7N
−アセチルアラントイラニレート、ブチルメトキシベン
ゾイルメタン、ジ−パラメトキシケイヒ酸−モノ−2−
エチルヘキサン酸グリセリル、アミルサリシレート、オ
クチルシンナメート、2、4−ジヒドロキシベンゾフェ
ノン等の紫外線吸収剤、グリセリン、1,3−ブチレン
グリコール、ポリエチレングリコール、ソルビトール、
キシレトール、マルチトール等の保湿剤、メチルセルロ
ース、アラビアガム、ポリビニルアルコール、モンモリ
ロナイト、ラポナイト等の増粘剤、ブチルヒドロキシト
ルエン、トコフェロール、フィチン酸等の酸化防止剤、
安息香酸、サリチル酸、ソルビン酸、パラオキシ安息香
酸アルキルエステル(エチルパラベン、ブチルパラベン
等)、ヘキサクロロフェン等の抗菌防腐剤、アシルサル
コシン酸例えばラウロイルコシンナトリウム)、グルタ
チオン、クエン酸、リンゴ酸、酒石酸、乳酸等の有機
酸、ビタミンAおよびその誘導体、ビタミンB6塩酸
塩、ビタミンB6トリパルミテート、ビタミンB6ジオク
タノエート、ビタミンB2およびその誘導体、ビタミン
B12、ビタミンB15およびその誘導体等のビタミンB
類、アスコルビン酸、アスコルビン酸硫酸エステル
(塩)、アスコルビン酸リン酸エステル(塩)、アスコ
ルビン酸ジパルミテート等のビタミンC類、α−トコフ
ェロール、β−トコフェロール、γ−トコフェロール、
ビタミンE−アセテ−ト、ビタミンE−ニコチネート等
のビタミンE類、ビタミンD類、ビタミンH、パントテ
ン酸、パントテチン等のビタミン類、ニコチン酸アミ
ド、ニコチン酸ベンジル、γ−オリザノール、アラント
イン、グリチルリチン酸(塩)、グリチルレチン酸およ
びその誘導体、ヒノキチオール、ムシジン、ビサボロー
ル、ユーカリプトール、チモールイノシトール、パント
テルエチルエーテル、エチニルエストラジオール、セフ
ァランジン、プラセンタエキス等の各種薬剤、ギシギ
シ、クララ、コウホネ、オレンジ、セージ、ノコギリ
草、ゼニアオイ、センキュウ、センブリ、タイム、トウ
キ、トウヒ、バーチ、スギナ、ヘチマ、マロニエ、ユキ
ノシタ、アルニカ、ユリ、ヨモギ、シャクヤク、アロ
エ、クチナシ、サワラ等の、有機溶媒、アルコール、多
価アルコール、水、水性アルコール等で抽出した天然エ
キス、色素などを本発明の効果を損なわない範囲で配合
することができる。In the water-in-oil type emulsion cosmetic of the present invention, in addition to the above essential components, para-aminobenzoic acid and homomethyl-7N.
-Acetyl allantoylanilate, butyl methoxy benzoyl methane, di-para methoxycinnamic acid-mono-2-
Glyceryl ethylhexanoate, amyl salicylate, octyl cinnamate, UV absorbers such as 2,4-dihydroxybenzophenone, glycerin, 1,3-butylene glycol, polyethylene glycol, sorbitol,
Xylitol, moisturizers such as maltitol, methyl cellulose, gum arabic, polyvinyl alcohol, montmorillonite, thickeners such as laponite, butylhydroxytoluene, tocopherol, antioxidants such as phytic acid,
Benzoic acid, salicylic acid, sorbic acid, alkyl esters of paraoxybenzoic acid (ethylparaben, butylparaben, etc.), antibacterial preservatives such as hexachlorophene, acyl sarcosinic acid (eg sodium lauroylcocin), glutathione, citric acid, malic acid, tartaric acid, lactic acid Organic acids such as Vitamin A and its derivatives, Vitamin B 6 hydrochloride, Vitamin B 6 tripalmitate, Vitamin B 6 dioctanoate, Vitamin B 2 and its derivatives, Vitamin B 12 , Vitamin B 15 and its derivatives, etc.
, Ascorbic acid, ascorbic acid sulfate (salt), ascorbic acid phosphate (salt), vitamin C such as ascorbic acid dipalmitate, α-tocopherol, β-tocopherol, γ-tocopherol,
Vitamin E-acetate, vitamin E-nicotinate, and other vitamins E, vitamin D, vitamin H, pantothenic acid, pantothetin, and other vitamins, nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizinic acid ( Salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalyptol, thymol inositol, pantoterethyl ether, ethinyl estradiol, cephalandin, placenta extract, and other drugs; Rumex, Clara, kohone, orange, sage, sawtooth Grass, mallow, senkyu, senburi, thyme, spruce, spruce, birch, horsetail, loofah, horse chestnut, yukinoshita, arnica, lily, mugwort, peony, aloe, gardenia, sawara etc. Organic solvents, alcohol, polyhydric alcohol, water, natural extract extracted with an aqueous alcohol, dyes and the like may be added in amounts not detrimental to the effects of the present invention.
【0016】[0016]
【実施例】次に、本発明を実施例および比較例によりさ
らに詳細に説明する。なお、%とあるのは、全て重量%
を意味する。実施例に先立ち、本発明で用いた評価法を
説明する。EXAMPLES Next, the present invention will be described in more detail with reference to Examples and Comparative Examples. All percentages are% by weight.
Means Prior to the examples, the evaluation method used in the present invention will be described.
【0017】[評価法]女性専門パネル約10人により
以下の評価基準に基づいて使用性の評価を行った。
(1) 使用感
肌上でののび
◎:非常にのびがよい。
○:のびがよい。
△:ややのびがよい。
×:のびが悪い。
べたつき
◎:非常にべたつきが少ない。
○:べたつきが少ない。
△:ややべたつく。
×:べたつく。
さっぱりさ
◎:非常にさっぱりする。
○:さっぱりする。
△:ややさっぱりする。
×:さっぱりしない。[Evaluation Method] The usability was evaluated by about 10 women specialized panels based on the following evaluation criteria. (1) Feel of use Spread on skin ◎: Very good spread. ◯: Good spread. Δ: Slightly stretched. X: The spread is poor. Stickiness ◎: Very little stickiness. ○: Little stickiness. Δ: Slightly sticky. X: Sticky. Refreshing ◎: Very refreshing. ○: Refreshed. Δ: A little refreshing. X: Not refreshed.
【0018】(2) 乳化安定性
クリームを、それぞれ50℃、37℃、室温および0℃
で1ケ月間放置し、その安定性を評価した。
◎:外観異常なし。
○:一部でわずかに油浮きしている。
△:油浮きしている。
×:分離している。(2) The emulsion-stabilized cream was prepared at 50 ° C., 37 ° C., room temperature and 0 ° C., respectively.
It was allowed to stand for 1 month at room temperature and its stability was evaluated. ⊚: No abnormality in appearance. ○: A part of the oil is floating. Δ: Oil is floating. X: Separated.
【0019】実施例1〜4、比較例1〜6
表1〜表2に記載した配合処方により乳液を調製し、使
用感および乳化安定性を評価した。その結果を表3に示
す。なお、オルガノポリシロキサンエストマー球状粉体
としては、トレフィルE−505Cを用いた。Examples 1 to 4 and Comparative Examples 1 to 6 Emulsions were prepared according to the formulations shown in Tables 1 and 2, and the feeling of use and emulsion stability were evaluated. The results are shown in Table 3. As the organopolysiloxane elastomer spherical powder, trefil E-505C was used.
【0020】[0020]
【表1】 ──────────────────────────────── 実 施 例 成分 (%) ─────────────── 1 2 3 4 ──────────────────────────────── スクワラン 5.0 5.0 5.0 5.0 ミリスチン酸イソプロピル 5.0 5.0 5.0 5.0 2−エチルヘキサン酸セチル 5.0 5.0 5.0 5.0 デカメチルシクロペンタシロキサン 10.0 5.0 5.0 5.0 ジメチルポリシロキサン 5.0 10.0 10.0 10.0オルカ゛ノホ゜リシロキサンエラストマー 球状粉体 3.0 3.5 3.5 0.2 ジメチルシリル化シリカ粉体 1.0 0.5 3.0 0.7 グリセロールイソステアレート(HLB=4) 3.0 3.0 3.0 3.0 L−グルタミン酸モノナトリウム 1.0 1.0 1.0 1.0 精製水 残部 残部 残部 残部 ジプロピレングリコール 10.0 10.0 10.0 10.0 ────────────────────────────────[Table 1] ──────────────────────────────── Example Ingredient (%) ─────────────── 1 2 3 4 ──────────────────────────────── Squalane 5.0 5.0 5.0 5.0 Isopropyl myristate 5.0 5.0 5.0 5.0 Cetyl 2-ethylhexanoate 5.0 5.0 5.0 5.0 Decamethylcyclopentasiloxane 10.0 5.0 5.0 5.0 Dimethylpolysiloxane 5.0 10.0 10.0 10.0 Organopolysiloxane elastomer Spherical powder 3.0 3.5 3.5 0.2 Dimethylsilylated silica powder 1.0 0.5 3.0 0.7 Glycerol isostearate (HLB = 4) 3.0 3.0 3.0 3.0 L-Glutamate monosodium 1.0 1.0 1.0 1.0 Purified water balance balance balance balance balance Dipropylene glycol 10.0 10.0 10.0 10.0 ────────────────────────────────
【0021】[0021]
【表2】 ─────────────────────────────────── 比 例 例 成分 (%) ─────────────────── 1 2 3 4 5 6 ─────────────────────────────────── スクワラン 10.0 10.0 10.0 10.0 5.0 5.0 ミリスチン酸イソプロピル 10.0 10.0 10.0 10.0 5.0 5.0 2−エチルヘキサン酸セチル 10.0 10.0 5.0 5.0 5.0 5.0 デカメチルシクロペンタシロキサン − − − − 10.0 10.0 ジメチルポリシロキサン − − 5.0 5.0 5.0 5.0オルカ゛ノホ゜リシロキサンエラストマー 球状粉体 3.0 3.0 3.0 3.0 2.0 0.3 ジメチルシリル化シリカ粉体 1.0 0.1 1.0 0.1 0.1 2.0 グリセロールイソステアレート(HLB=4) 3.0 3.0 3.0 3.0 3.0 3.0 L−グルタミン酸モノナトリウム 1.0 1.0 1.0 1.0 1.0 1.0 精製水 残部 残部 残部 残部 残部 残部 ジプロピレングリコール 10.0 10.0 10.0 10.0 10.0 10.0 ───────────────────────────────────[Table 2] ─────────────────────────────────── Comparative example Ingredient (%) ─────────────────── 1 2 3 4 5 6 ─────────────────────────────────── Squalane 10.0 10.0 10.0 10.0 5.0 5.0 Isopropyl myristate 10.0 10.0 10.0 10.0 5.0 5.0 Cetyl 2-ethylhexanoate 10.0 10.0 5.0 5.0 5.0 5.0 Decamethylcyclopentasiloxane − − − − 10.0 10.0 Dimethyl polysiloxane --5.0 5.0 5.0 5.0 Organopolysiloxane elastomer Spherical powder 3.0 3.0 3.0 3.0 2.0 0.3 Dimethylsilylated silica powder 1.0 0.1 1.0 0.1 0.1 2.0 Glycerol isostearate (HLB = 4) 3.0 3.0 3.0 3.0 3.0 3.0 L-Glutamate monosodium 1.0 1.0 1.0 1.0 1.0 1.0 Purified water balance balance balance balance balance balance balance balance Dipropylene glycol 10.0 10.0 10.0 10.0 10.0 10.0 ───────────────────────────────────
【0022】[0022]
【表3】 ─────────────────────────────────── (1)使用感 (2)乳化安定性 評価 ─────────────────────────────── 肌上でののび べたつき さっぱり感 0℃ 室温 37℃ 50℃ ─────────────────────────────────── 実施例1 ◎ ◎ ◎ ◎ ◎ ◎ ◎ 実施例2 ◎ ◎ ◎ ◎ ◎ ◎ ◎ 実施例3 ◎ ◎ ◎ ○ ◎ ◎ ◎ 実施例4 ◎ ◎ ◎ ◎ ◎ ◎ ○ ─────────────────────────────────── 比較例1 ○ ○ × ◎ ◎ ◎ ◎ 比較例2 ○ ○ × ◎ ◎ ○ ○ 比較例3 ○ ◎ △ ◎ ◎ ◎ ◎ 比較例4 ◎ ◎ △ ◎ ◎ ○ ○ 比較例5 ◎ ◎ ◎ ◎ ◎ ○ △ 比較例6 ◎ △ △ ◎ ◎ ○ △ ───────────────────────────────────[Table 3] ─────────────────────────────────── (1) Usability (2) Emulsion stability Evaluation ─────────────────────────────── Smoothness on the skin, refreshing feeling 0 ℃, room temperature 37 ℃ 50 ℃ ─────────────────────────────────── Example 1 ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ Example 2 ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ Example 3 ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ Example 4 ◎ ◎ ◎ ◎ ◎ ◎ ◎ ○ ─────────────────────────────────── Comparative Example 1 ○ ○ × ◎ ◎ ◎ ◎ ◎ Comparative Example 2 ○ ○ × ◎ ◎ ○ ○ Comparative Example 3 ○ ◎ △ ◎ ◎ ◎ ◎ ◎ Comparative Example 4 ◎ ◎ △ ◎ ◎ ○ ○ ○ Comparative Example 5 ◎ ◎ ◎ ◎ ◎ ◎ ○ △ Comparative Example 6 ◎ △ △ ◎ ◎ ○ △ ───────────────────────────────────
【0023】
実施例5 保湿クリーム
(1) 精製水 残部
(2) 乳酸Na 1.0 重量%
(3) 1,3−ブチレングリコール 5.0
(4) 流動パラフィン 5.0
(5) セチル−2−エチルヘキサノエート 5.0
(6) ペンタエリスリトール
テトラ−2−エチルヘキサノエート 3.0
(7) メチルフェニルポリシロキサン 3.0
(8) デカメチルシクロペンタシロキサン 10.0
(9) トレフィルE−505C 2.5
(10) アエロジルR972 2.0
(11) シリコンSC9450N 2.0
(信越シリコーン社製,HLB=4.5)
(12) ビタミンE−アセテート 3.0
(13) メチルパラベン 適量
(14) 香料 適量
(製法)(4),(5),(6),(7),(8),(11),(12),(14)を室温に
て混合した油相に、(9),(10)の粉体を徐添しながら均
一に分散を行う。その後、(1)に(2)を溶解したものに、
(3)に(13)を溶解したものを加えた水相を前記油相に徐
添し、ホモミキサーで均一分散後、乳化粒子を整え、保
湿クリームを得る。Example 5 Moisturizing cream (1) Purified water balance (2) Na lactate 1.0% by weight (3) 1,3-butylene glycol 5.0 (4) Liquid paraffin 5.0 (5) Cetyl-2 -Ethylhexanoate 5.0 (6) Pentaerythritol Tetra-2-ethylhexanoate 3.0 (7) Methylphenylpolysiloxane 3.0 (8) Decamethylcyclopentasiloxane 10.0 (9) Trefil E -505C 2.5 (10) Aerosil R972 2.0 (11) Silicon SC9450N 2.0 (Shin-Etsu Silicone Co., HLB = 4.5) (12) Vitamin E-acetate 3.0 (13) Methylparaben Suitable amount (14 ) Fragrance (manufacturing method) (4), (5), (6), (7), (8), (11), (12), (14) in the oil phase mixed at room temperature, (9) , (10) powder is gradually added and dispersed uniformly. Then, in (1) dissolved in (2),
An aqueous phase obtained by adding the solution of (13) to (3) is gradually added to the oil phase, uniformly dispersed by a homomixer, and then emulsion particles are prepared to obtain a moisturizing cream.
【0024】
実施例6 乳液
(1) 精製水 残部
(2) 食塩 1.0 重量%
(3) ポリエチレングリコール11000 1.0
(4) プロピレングリコール 8.0
(5) スクワレン 5.0
(6) ペンタエリスリトール
テトラ−2−エチルヘキサノエート 5.0
(7) メチルフェニルポリシロキサン 5.0
(8) オクタメチルシクロテトラシロキサン 15.0
(9) トレフィルE−505C 2.0
(10) アエロジルR972 0.5
(11) シリコンSC9450N 3.0
(信越シリコーン社製,HLB=4.5)
(12) アスコルビン酸リン酸マグネシウム 1.0
(13) メチルパラベン 適量
(14) 香料 適量
(製法)(5),(6),(7),(8),(11),(14)を室温にて混合し
た油相に、(9),(10)の粉体を徐添しながら均一に分散を
行う。その後、(1)に(2),(3),(12)を溶解したものに、
(4)に(13)を溶解したものを加えた水相を前記油相に徐
添し、ホモミキサーで均一分散後、乳化粒子を整え、乳
液を得る。Example 6 Emulsion (1) Purified water Balance (2) Salt 1.0% by weight (3) Polyethylene glycol 11000 1.0 (4) Propylene glycol 8.0 (5) Squalene 5.0 (6) Penta Erythritol tetra-2-ethylhexanoate 5.0 (7) Methylphenylpolysiloxane 5.0 (8) Octamethylcyclotetrasiloxane 15.0 (9) Trefil E-505C 2.0 (10) Aerosil R972 0. 5 (11) Silicon SC9450N 3.0 (manufactured by Shin-Etsu Silicone Co., Ltd., HLB = 4.5) (12) Magnesium ascorbyl phosphate 1.0 (13) Methylparaben Appropriate amount (14) Perfume Appropriate amount (production method) (5), ( The powders of (9) and (10) are gradually added to the oil phase obtained by mixing 6), (7), (8), (11) and (14) at room temperature while uniformly dispersing them. Then, in (2), (3), (12) dissolved in (1),
An aqueous phase obtained by adding the solution of (13) to (4) is gradually added to the oil phase, uniformly dispersed with a homomixer, and then emulsion particles are prepared to obtain an emulsion.
【0025】
実施例7 日焼け防止用乳液
(1) 精製水 残部
(2) ポリエチレングリコール6000 1.0 重量%
(3) グルタミン酸Na 1.0
(4) プロピレングリコール 8.0
(5) ペンタエリスリトール
テトラ−2−エチルヘキサノエート 10.0
(6) セチル−2−エチルヘキサノエート 5.0
(7) メチルフェニルポリシロキサン 5.0
(8) デカメチルシクロペンタシロキサン 15.0
(9) トレフィルE−506C 2.0
(10) アエロジルR972 0.5
(11) シリコンSC9450N 1.0
(信越シリコーン社製,HLB=4.5)
(12) ジグリセロールモノオレート(HLB=6.5) 2.0
(13) オクチルメトキシシンナメート 適量
(14) 2,4−ジヒドロキシベンゾフェノン 適量
(15) メチルパラベン 適量
(16) 香料 適量
(製法)(5),(6),(7),(8),(11),(12),(13),(14),(16)を
室温にて混合した油相に、(9),(10)の粉体を徐添しなが
ら均一に分散を行う。その後、(1)に(2),(3)を溶解した
ものに、(4)に(15)を溶解したものを加えた水相を前記
油相に徐添し、ホモミキサーで均一分散後、乳化粒子を
整え、日焼け防止用乳液を得る。Example 7 Sunscreen Emulsion (1) Purified Water Remainder (2) Polyethylene Glycol 6000 1.0 wt% (3) Glutamate Na 1.0 (4) Propylene Glycol 8.0 (5) Pentaerythritol Tetra- 2-Ethylhexanoate 10.0 (6) Cetyl-2-ethylhexanoate 5.0 (7) Methylphenylpolysiloxane 5.0 (8) Decamethylcyclopentasiloxane 15.0 (9) Trefil E- 506C 2.0 (10) Aerosil R972 0.5 (11) Silicon SC9450N 1.0 (manufactured by Shin-Etsu Silicone Co., Ltd., HLB = 4.5) (12) Diglycerol monooleate (HLB = 6.5) 2.0 ( 13) Octyl methoxycinnamate Appropriate amount (14) 2,4-Dihydroxybenzophenone Appropriate amount (15) Methylparaben Appropriate amount (16) Perfume Appropriate amount (Production method) (5), (6), (7), (8), (11), (12), ( The powders of (9) and (10) are gradually added to the oil phase obtained by mixing 13), (14) and (16) at room temperature while uniformly dispersing them. Then, (2) in (1), (3) was dissolved, the aqueous phase obtained by adding (15) in (4) was slowly added to the oil phase, and after homogenous dispersion with a homomixer. The emulsion particles are prepared to obtain a sunscreen emulsion.
【0026】[0026]
【発明の効果】以上説明したように、本発明によれば、
良好な乳化状態を呈し、温度や経時による変化がなく、
のびのよいさっぱりとした良好な使用感を有する油中水
型乳化化粧料を得ることができる。As described above, according to the present invention,
It exhibits a good emulsified state and does not change with temperature or with time.
It is possible to obtain a water-in-oil type emulsified cosmetic having a smooth and refreshing feeling of use.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平3−72942(JP,A) 特開 平7−61907(JP,A) 特開 平6−40847(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 ─────────────────────────────────────────────────── ─── Continuation of front page (56) References JP-A-3-72942 (JP, A) JP-A-7-61907 (JP, A) JP-A-6-40847 (JP, A) (58) Field (Int.Cl. 7 , DB name) A61K 7/ 00-7/50
Claims (3)
径分布1〜15μmのオルガノポリシロキサンエラスト
マー球状粉体と(B)平均粒径0.2μm以下の疎水化
シリカ粉体とからなり、(A)対(B)の割合が重量比
で1:0.1〜1:5である混合粉体と、(C)総油相
成分の30重量%以上がシリコーン油である油相と、
(D)ソルビタン脂肪酸エステル類、グリセロール脂肪
酸エステル類、ポリオキシエチレン硬化ヒマシ油、ポリ
エーテル系シリコーン活性剤から選ばれ、HLBが7以
下の乳化剤と、(E)水とからなることを特徴とする油
中水型乳化化粧料。1. (A) Organopolysiloxane elastomer spherical powder having an average particle size of 2.0 to 5.0 μm and a particle size distribution of 1 to 15 μm, and (B) a hydrophobized silica powder having an average particle size of 0.2 μm or less. And a mixed powder having a weight ratio of (A) to (B) of 1: 0.1 to 1: 5, and (C) 30% by weight or more of the total oil phase component is silicone oil. Oil phase,
(D) Sorbitan fatty acid esters, glycerol fat
Acid esters, polyoxyethylene hydrogenated castor oil, poly
A water-in-oil type emulsion cosmetic comprising an emulsifier having an HLB of 7 or less and (E) water, which is selected from ether-based silicone activators .
(C)油の割合が重量比で1:5〜1:30である請求
項1記載の油中水型乳化化粧料。2. The water-in-oil type emulsified cosmetic composition according to claim 1, wherein the weight ratio of the mixed powder of (A) + (B) to the oil of (C) is 1: 5 to 1:30.
0〜90.0重量%、(D)HLBが7以下の乳化剤の
配合量が0.1〜5.0重量%、(E)水の配合量が
9.0〜90.0重量%である請求項2記載の油中水型
乳化化粧料。3. The compounding amount of (A) + (B) + (C) is 9.
0 to 90.0% by weight, (D) HLB of 7 or less is included in an amount of 0.1 to 5.0% by weight, and (E) water is included in an amount of 9.0 to 90.0% by weight. The water-in-oil emulsion cosmetic according to claim 2.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27712295A JP3406437B2 (en) | 1995-09-29 | 1995-09-29 | Water-in-oil emulsion cosmetics |
| EP96115382A EP0765656B1 (en) | 1995-09-29 | 1996-09-25 | Water-in-oil type emulsion cosmetic composition |
| DE69613647T DE69613647T2 (en) | 1995-09-29 | 1996-09-25 | Cosmetic preparation containing water-in-oil emulsion |
| KR1019960042307A KR100472632B1 (en) | 1995-09-29 | 1996-09-25 | In-water type emulsion cosmetic composition |
| US08/723,937 US5853711A (en) | 1995-09-29 | 1996-09-26 | Water-in-oil emulsion cosmetic composition |
| TW085111831A TW449484B (en) | 1995-09-29 | 1996-09-26 | Water-in-oil type emulsion cosmetic composition having a good spreadability, a fresh feeling in use and good stability |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27712295A JP3406437B2 (en) | 1995-09-29 | 1995-09-29 | Water-in-oil emulsion cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0995434A JPH0995434A (en) | 1997-04-08 |
| JP3406437B2 true JP3406437B2 (en) | 2003-05-12 |
Family
ID=17579101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP27712295A Expired - Fee Related JP3406437B2 (en) | 1995-09-29 | 1995-09-29 | Water-in-oil emulsion cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3406437B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10291925A (en) * | 1997-04-18 | 1998-11-04 | Kao Corp | Skin cosmetics |
| KR100500902B1 (en) * | 1997-12-02 | 2005-11-08 | 주식회사 엘지생활건강 | Water in oil emulsion cosmetic composition |
| JP4538377B2 (en) * | 2005-06-03 | 2010-09-08 | マルホ株式会社 | Water-in-oil emulsion composition |
-
1995
- 1995-09-29 JP JP27712295A patent/JP3406437B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0995434A (en) | 1997-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69821180T2 (en) | Stable topical compositions with a solid elastomeric organopolysiloxane and spherical particles | |
| US5015469A (en) | Water-in-oil emulsion type cosmetics | |
| US5412004A (en) | Silicone polymer, paste-like silicone composition, and w/o-type cosmetic composition comprising the same | |
| EP1904021B1 (en) | Low viscosity, unstable water-in-silicone emulsion cosmetic compositions and methods of use thereof | |
| DE69005029T2 (en) | Stable water-free composition for the topical delivery of active materials. | |
| JP3474720B2 (en) | Water-in-oil emulsion cosmetics | |
| JP3524717B2 (en) | Water-in-oil emulsion composition and emulsified cosmetic using the same | |
| JPH1067644A (en) | Composition comprising a combination of a volatile compound and a phenylated silicone oil and a hydrophilic component, and use thereof | |
| JP3440437B2 (en) | O / W / O emulsion composition | |
| JP3406437B2 (en) | Water-in-oil emulsion cosmetics | |
| JP3406438B2 (en) | Water-in-oil emulsion cosmetics | |
| JP2004051505A (en) | Oil-in-water type cosmetic | |
| JP4553607B2 (en) | Oil-in-water emulsified fragrance composition and method for producing the same | |
| JP3824340B2 (en) | Water-in-oil emulsified cosmetic | |
| JP3535322B2 (en) | External preparation for skin | |
| JP2001131016A (en) | Composition for external use | |
| JP3811919B2 (en) | Multi-layer cosmetic | |
| JP2009137909A (en) | Astringent cosmetic | |
| JP2004067628A (en) | Water-in-oil type emulsified composition | |
| JPH10226622A (en) | Water-in-oil type emulsified composition and emulsified cosmetic using the same | |
| JP3529223B2 (en) | Water-in-oil gel emulsion composition and emulsified cosmetic or external preparation using the same | |
| JPH04178316A (en) | Emulsion cosmetic | |
| JP2000178124A (en) | Body cosmetics | |
| JP2001354510A (en) | Oil-in-water type composition for external use | |
| JPH09124437A (en) | Emulsified composition and dermal preparation for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20030225 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090307 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090307 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100307 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100307 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110307 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120307 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120307 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130307 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140307 Year of fee payment: 11 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |